Benign or borderline malignant neoplasm of the ovary and surrounding tissues. It is characterized by tumor(s) with cystic glands which are lined by cuboidal EPITHELIAL CELLS with clear cytoplasm, resembling ENDOMETRIUM cells. The glands are separated by fibroblastic STROMAL CELLS.
A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)
Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes (peritoneum, pericardium, pleura). The concept does not refer to neoplasms located in these organs. (From Dorland, 27th ed)
A benign neoplasm of the ovary.
A highly malignant CHORIOCARCINOMA derived from the non-placental origin such as the totipotent cells in the TESTIS, the OVARY, and the PINEAL GLAND. It produces high levels of CHORIONIC GONADOTROPIN and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.

Anti-N-methyl-d-aspartate encephalitis with ovarian cystadenofibroma. (1/2)

 (+info)

Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI. (2/2)

Clear cell adenofibroma (CCAF) is a rare surface epithelial-stromal tumor of the ovary and recently considered another precursor of clear cell adenocarcinoma (CCA) other than endometrioma. We report magnetic resonance (MR) findings of a borderline CCAF that contained a small CCA focus. The tumor manifested a characteristic "black sponge" appearance. The CCA focus showed high signal intensity on diffusion-weighted imaging (DWI) and early enhancement on dynamic contrast-enhanced (DCE) MR imaging (DCE-MRI), and the CCAF components showed low signal intensity on DWI and gradually increasing contrast enhancement on DCE-MRI.  (+info)

Given its size, solid components, and enhancment characteristics, surgical excision was recommended. Differential considerations Ovarian cystadenofibroma Ovarian cystadenocarcinoma Sclerosing stromal tumor of the ovary Ovarian masses with f...
Benign or borderline malignant neoplasm of the ovary and surrounding tissues. It is characterized by tumor(s) with cystic glands which are lined by cuboidal EPITHELIAL CELLS with clear cytoplasm, resembling ENDOMETRIUM cells. The glands are separated by fibroblastic STROMAL CELLS ...
Looking for online definition of adenofibroma edematodes in the Medical Dictionary? adenofibroma edematodes explanation free. What is adenofibroma edematodes? Meaning of adenofibroma edematodes medical term. What does adenofibroma edematodes mean?
Title:Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report. VOLUME: 16 ISSUE: 8. Author(s):Jiyun Oh, Sung Bin Park*, Byoung Hee Han, Hye-Sun Kim, Eun Sun Lee and Hyun Jeong Park. Affiliation:Department of Radiology, Chung-Ang University Hospital, Seoul, Department of Radiology, Chung-Ang University Hospital, Seoul, Department of Radiology, Gangneung Asan Hospital, College of Medicine, University of Ulsan, Gangneung, Department of Pathology, Mizmedi Hospital, Seoul, Department of Radiology, Chung-Ang University Hospital, Seoul, Department of Radiology, Chung-Ang University Hospital, Seoul. Keywords:Adenofibroma, carcinosarcoma, malignant transformation of adenofibroma, magnetic resonance imaging.. Abstract:Background: Adenofibroma is a benign tumor composed histologically of epithelial elements and mesenchymal stroma. Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma. Carcinosarcoma arising from adenofibroma of the uterus ...
MalaCards based summary : Nephrogenic Adenofibroma, also known as metanephric adenofibroma, is related to thymus lipoma and adult endodermal sinus tumor. An important gene associated with Nephrogenic Adenofibroma is MAF (MAF BZIP Transcription Factor), and among its related pathways/superpathways are Developmental Biology and Transcriptional misregulation in cancer. Affiliated tissues include kidney, and related phenotypes are Decreased sensitivity to paclitaxel and embryo ...
MalaCards based summary : Papillary Adenofibroma is related to adenofibroma and congenital granular cell tumor. An important gene associated with Papillary Adenofibroma is PTEN (Phosphatase And Tensin Homolog), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Platelet Aggregation Inhibitor Pathway, Pharmacodynamics. Affiliated tissues include liver, heart and cervix, and related phenotypes are hematopoietic system and homeostasis/metabolism ...
Women experiencing ovarian vulgaris do not have the normal discharge of the body hormone or LH, the chemical substance that encourages the egg to be unveiled from the hair foillicle monthly. After having a patient may be stabilized, undoubtedly usually an infection to some degree because of fluids that have been dispersed through the ruptured cyst.. On the basis of this kind of CT the distinction among a harmless ovarian ofensa such as when cystadenofibroma and a cancerous ovarian ofensa cannot be manufactured. If you have vulgaris, you will be experiencing discomfort in your returning because of the pressure on the urinary, kidneys and also other internal organs.. This is certainly so specially in cases wherever an endometriod cyst will rupture and thus ultimately causing its details being leaking into the fallopian tubes as well as the uterus. Abdomen pain, bloating and all sorts of digestive problems could be associated with ovarian cysts. Ovarian cysts tend not to preclude you from ...
Low expression of S100P is associated with poor prognosis in patients with clear cell adenocarcinoma of the ovaryLow expression of S100P is associated with poor prognosis in patients with clear cell adenocarcinoma of the ovary ...
Adenofibroma is a benign tumor composed histologically of epithelial elements and mesenchymal stroma. Carcinosarcoma is a malignant neoplasm that contains eleme
Build: Wed Jun 21 18:33:50 EDT 2017 (commit: 4a3b2dc). National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888. ...
TY - JOUR. T1 - Clear cell adenocarcinoma presenting as acute pancreatitis. T2 - a rare form of primary pancreatic malignancy. AU - ONeill, Robert S.. AU - Lam, Lyn L.. AU - Solanki, Parthsinh. AU - Levingston, Robyn. AU - Thomas, David. PY - 2020/10/1. Y1 - 2020/10/1. N2 - Background: Pancreatic cancer is associated with a dismal prognosis, with ductal adenocarcinoma being the most common form of primary neoplasm diagnosed. Clear cell carcinoma is usually associated with kidney, ovarian or bladder malignancy but rarely associated with pancreatic malignancy. According to the WHO classification, primary clear cell adenocarcinoma of the pancreas is a rare miscellaneous carcinoma, and to date few cases have been reported in the literature. Case: A 63-year old female who presented to a metropolitan hospital in Australia with abdominal pain suggestive of pancreatitis. Abdominal computed tomography subsequently demonstrated a necrotic mass in the neck of the pancreas with hepatic metastasis. ...
The therapeutic effect of a combination of paclitaxel (PTX) and platinum (PLT) in ovarian clear cell adenocarcinoma (CC) patients with measurable disease has yet to be elucidated. In this study, we used retrospective review to evaluate the results of treatment with a combination of PTX and PLT in CC patients with measurable disease. A total of 28 patients with measurable residual CC (15 cases with primary disease, 13 cases with recurrent disease) treated with combination PTX-PLT chemotherapy was identified through medical records from ten institutions. Clinical response to chemotherapy was evaluated using Response Evaluation Criteria in Solid Tumors criteria. Of the 28 cases, 8 of 15 patients with primary disease (53.3%) and 3 of 13 patients with recurrent disease (23.1%) responded to PTX-PLT chemotherapy. The response rate for cases with late recurrent disease (,12 months) was 20% (1/5), whereas the rate was 25% (2/8) for cases with early recurrent (,12 months) or refractory disease. Our ...
TY - JOUR. T1 - Ovarian clear cell adenocarcinoma revealed in a young patient during hormone therapy: a case report. AU - Kawai, Satoshi. AU - Ichikawa, Ryoko. AU - Ueda, Takahiro. AU - Urano, Makoto. AU - Kuroda, Makoto. AU - Fujii, Takuma. PY - 2016. Y1 - 2016. U2 - 10.20407/fmj.2.4_77. DO - 10.20407/fmj.2.4_77. M3 - Article. VL - 2. SP - 77. EP - 79. JO - Fujita medical journal. JF - Fujita medical journal. SN - 2189-7247. IS - 4. ER - ...
The patient received a potassium supplement, intramuscular administration of calcitonin, and intravenous (IV) fluid hydration, and she was admitted to the hospital for further workup. After treatment with IV fluids, calcitonin, and zoledronic acid, her calcium level decreased to 11.5 mEq/L. With improvement of her nausea and vomiting, the patient was discharged. It was recommended that she follow-up with an oncologist as an outpatient.. Approximately 1 week later, the patient returned to the Emergency Department with similar symptoms and was found to have an elevated calcium level of 15 mEq/L. She was given IV fluids and pamidronate, which improved her symptoms. She was discharged, with further workup to be done on an outpatient basis. This patient presented a total of 4 times to the Emergency Department with similar symptoms of hypercalcemia, as shown in Figure 1.. A bone marrow biopsy was performed, and the specimen demonstrated trilineage hematopoiesis without signs of myeloma. Specifically, ...
Clear cell adenocarcinoma is most often seen in the vagina, however, they can also arise in the cervix (as in our case). These neoplasms may be sporadic or associated with in utero exposure to DES. Diethylstilbestrol or DES was prescribed for women during between 1940 to early 1970s for the prevention of miscarriages. This practice was stopped once DES was discovered to be a teratogen, however, approximately 2 million women in the United States were exposed to DES in utero ...
Thus investigators should avoid using maternal recall alone to measure DES exposure. Among subjects for whom written maternal obstetric records were available, 88% of vaginal cases and 46% of cervical cases were DES positive. The authors conclude that few cases of vaginal clear cell adenocarcinoma should occur in young women as the cohort of women exposed in utero to DES continues to age, whereas cases of cervical origin may continue to occur.. Sources: Clear cell adenocarcinoma of the lower genital tract. Correlation of mothers recall of diethylstilbestrol history with obstetrical records, NCBI, Dr Herbst A, Nov 1990. See also: Are you a probable DES Daughter ...
Malignant Tumors of Female Internal Genitalia & Ovaries - UrologyWeb Clear cell adenocarcinoma of the vagina and cervix is rare. The increase and occurrence of this tumor has been linked with the maternal use of
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physicians choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA) ...
This is an international, randomised, double blind, placebo controlled, parallel group study to investigate whether a minimum of three doses of TroVax® added to first-line standard of care therapy, prolongs the survival of patients with locally advanced or metastatic renal clear cell adenocarcinoma.. The primary endpoint is survival. The study is designed to be pragmatic, limiting additional study related investigations to a minimum. Protocol mandated scans and X-rays are limited to two time points (baseline and week 26) to permit comparison of the percentage of patients with progressive disease at 6 months as a secondary efficacy endpoint. Six months was selected based on review of published literature indicating that progressive disease was commonly observed by 26 weeks in patients with renal cancer. Endpoints such as tumour response by RECIST are considered of secondary importance to survival and will be determined by radiological examinations ordered at the discretion of the investigator ...
The 1993 Damon Challenger that I am looking at has lap belts only for the drivers side and passenger side captains chairs, no shoulder harness? I have looked at other Damon motorhomes from that era
Clear cell adenocarcinoma of endobronchial origin is rare with only two case reports identified in a Pubmed search [1, 2]. Both of these reported cases occurred in adults, 45 years and 65 years of age. Our case is of a younger adult male of 27 years of age. The main differential diagnosis in this case is to rule out an adenocarcinoma with focal clear cell features, fetal adenocarcinoma, metastatic renal cell carcinoma, in additional to clear cell (sugar) tumor. The immunohistochemical stains being negative for CK5/6 and P63, as well as TTF1 and napsin A would make a diagnosis of either a squamous cell carcinoma or adenocarcinoma with clear cell features unlikely. The renal cell markers are negative. Sugar tumors are classically HMB-45 positive, and therefore our tumor is not in that category. The positivity of CK7 and PAS/PAS-D support an epithelial origin with glycogen positive cytoplasm. In our case, as well as the two case reports, this type of clear cell adenocarcinoma is known for an ...
Primary signet cell carcinoma of the prostate is a rare histological variant of prostate malignancies. It is commonly originated from the stomach, colon, pancreas, and less commonly in the bladder. Prognosis of the classical type is worse than the adenocarcinoma of the prostate. Primary signet cell adenocarcinoma is diagnosed by eliminating the adenocarcinomas of other organs such as gastrointestinal tract organs. In this case report, we present a case with primary signet cell adenocarcinoma of the prostate who received docetaxel chemotherapy because of short prostate specific antigen doubling time ...
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patients clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician ...
A 2-year-old youngster with prenatal analysis of a malformation uropathy was described paediatric surgery division. neoplasm Intro Metanephric stromal tumor (MST) can be a rare, harmless paediatric renal neoplasm that was reported for the very first time by Argani and Beckwith in 2000 through some 31 instances.[1] It occurs in VX-765 price the very first year of existence. The mean age group at diagnosis can be two years and they have rarely been referred to in adults.[1] MST signifies a spectral range of well-differentiated nephroblastic lesions with metanephric adenofibroma and metanephric adenoma that look like linked to Wilms tumor (WT).[2,3] Its quality microscopic appearance and immunohistochemical profile really helps to distinguish between MST and very clear cell sarcoma of kidney (CCSK) and congenital mesoblastic nephroma (CMN).[1] Recently, a cytogenetic characterization was referred to and it includes a complicated 17q rearrangement.[4] An instance operated for renal artery aneurysm ...
The timing and location of the DES (Diethylstilbestrol) symposium have historical significance. In the late 1960s, there was an unprecedented appearance of a rare vaginal cancer in young women. Cases of Clear Cell Adenocarcinoma (CCA) were diagnosed in an age group never before found to develop it. A DES mother raised the question of whether her daughters vaginal cancer might be connected to DES exposure in utero. Doctors confirmed the link between DES and cancer in 1971 and published their findings in the April 1971 issue of the New England Journal of Medicine. It is at the MGH that the DES cancer link was first made on April 22, 1971.. In 2011, in the USA and in many other corners of the world, diethylstibestrol continues to affect the lives of not only the DES mothers who were prescribed the carcinogenic drug, the lives of their daughters and sons who have been exposed in utero, but also the lives of their grandchildren. And unfortunately, cancer is not the only health issue that has been ...
Disorders associated with the ZFY gene include campomelic dysplasia, cystadenofibroma, and Frasier syndrome. GRCh38: Ensembl ...
... clear cell cystadenofibroma M8313/1 Clear cell adenofibroma of borderline malignancy Clear cell cystadenofibroma of borderline ... NOS Cystadenofibroma, NOS Papillary adenofibroma M9014/0 Serous adenofibroma, NOS Serous cystadenofibroma, NOS M9014/1 Serous ... NOS Mucinous cystadenofibroma, NOS M9015/1 Mucinous adenofibroma of borderline malignancy Mucinous cystadenofibroma of ... NOS Endometrioid cystadenofibroma, NOS M8381/1 Endometrioid adenofibroma, borderline malignancy Endometrioid cystadenofibroma, ...
AND CYSTADENOFIBROMA The serous epithelial tumors of the ovary include three subgroups in which the fibromatous elemen ... PAPILLOMA, SEROUS ADENOFIBROMA, AND CYSTADENOFIBROMA pediagenosis November 13, 2021 Organ , Reproductive Comment ...
cystadenofibroma A cystadenofibroma is an ovarian adenofibroma. → Definition and anagrams of cystadenofibroma. → Other senses ...
Malignancy Look Alike: A Rare Case of Ovarian Serous Cystadeno-Fibroma; A Case Report. Dr. Pratibha Lambodari , Dr. Ruchi ...
Atypical endometrioid cystadenofibroma with Meigs syndrome: ultrastructure and S-phase fraction. Cancer. 1982 Feb 1. 49(3):472 ...
Cystadenofibroma Active Synonym false false Associated Value Sets Value Set Name Version(s) ...
Borderline Cystadenofibroma Borderline Cystadenofibromas Cystadenofibroma, Borderline Cystadenofibromas, Borderline Benign ... Benign Cystadenofibroma. Benign Cystadenofibromas. Borderline Clear Cell Adenofibroma. Borderline Cystadenofibroma. Borderline ... Cystadenofibroma, Benign. Cystadenofibroma, Borderline. Cystadenofibromas. Cystadenofibromas, Benign. Cystadenofibromas, ... Cystadenofibroma - Preferred Concept UI. M0568819. Scope note. Benign or borderline malignant neoplasm of the ovary and ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
RATIONALE: Ovarian cystadenofibroma is a relatively rare benign ovarian tumor. Ovarian remnant syndrome (ORS) is a rare ... Ovarian remnant syndrome with paraintestinal ovarian serous cystadenofibroma arose 30 years after bilateral salpingo- ... OUTCOMES: Histopathological examination revealed an ovarian serous cystadenofibroma. The postoperative recovery was uneventful ... We report a rare case of ORS with paraintestinal ovarian serous cystadenofibroma that developed 30 years after total abdominal ...
An unusual presentation of huge paraovarian cyst as papillary serous cyst adenofibroma: a rare case report ...
Dhingra KK, Jain P, Garg A, Khurana N. Coexistent struma ovarii and serous cystadenofibroma in the same ovary. Int J Gynecol ...
serous cystadenoma / serous cystadenofibroma *borderline cystadenoma. *serous cystadenocarcinoma. * mucinous tumors *ovarian ...
Cystadenofibroma [C04.557.470.590.482] * Cystadenoma [C04.557.470.590.485] * Mucoepidermoid Tumor [C04.557.470.590.580] ...
... code of practice 2014 implications kensington lock slot macbook pro strokes ill try anything once traduzione cystadenofibroma ...
Cystadenofibroma [C04.557.450.565.590.595.050.500] Cystadenofibroma * Brenner Tumor [C04.557.450.565.590.595.150] ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Cystadenofibroma. Cistoadenofibroma. Cistoadenofibroma. Lipoblastoma. Lipoblastoma. Lipoblastoma. C05 - Musculoskeletal ...
Serous cystadenofibroma. *serous cystadenoma. *serous cystic carcinoma. *serous cystoma. *serous detachment. *serous detachment ...
Ovarian Serous Cystadenofibroma. OVR002. Ovarian Sex-Cord Stromal Tumor. OVR121. Ovarian Small Cell Carcinoma. OVR058. SCCO. ...
Cystadenofibroma. Brenner. Adapted from: Robbins and Cotran; Pathologic Basis of Disease, 7th Ed Copyright © 2005 Elsevier ...
OR cystadenofibroma [tw]. OR cystadenofibromas [tw]. OR cystadenoma [tw]. OR cystadenomas [tw]. OR cystoma [tw]. OR cystomas [ ...
A ruptured ovarian cystadenofibroma presenting with life-threatening sepsis and an incidental synchronous endometrial stromal ...
Atypical endometrioid cystadenofibroma with Meigs syndrome: ultrastructure and S-phase fraction. Cancer. 1982 Feb 1. 49(3):472 ...
9. Radioiodine accumulation in a large adnexal cystadenofibroma.. Turker O; Dogan I; Kumanlioglu K. Thyroid; 2010 May; 20(5): ...
a) ovary with mucinous cystadenoma, and (b) ovary with cystadenofibroma. Scale bar: 500 μm. ...
Coexistence of ovarian serous papillary cystadenofibroma and type A insulin resistance syndrome in a 14-year-old girl: A case ...
Cystadenofibroma,modify,30-APR-07,(null),(null) C65763,Fosmenic_Acid,modify,30-APR-07,(null),(null) C65368,Deslanoside,modify, ...
Benign Cystadenofibroma Borderline Clear Cell Adenofibroma Borderline Cystadenofibroma Clear Cell Adenofibroma Previous ... Cystadenofibroma Preferred Term Term UI T813855. Date12/06/2011. LexicalTag NON. ThesaurusID NLM (2013). ... Borderline Cystadenofibroma Term UI T813879. Date12/07/2011. LexicalTag NON. ThesaurusID NLM (2013). ... Benign Cystadenofibroma Term UI T813878. Date12/07/2011. LexicalTag NON. ThesaurusID NLM (2013). ...
Benign Cystadenofibroma Borderline Clear Cell Adenofibroma Borderline Cystadenofibroma Clear Cell Adenofibroma Previous ... Cystadenofibroma Preferred Term Term UI T813855. Date12/06/2011. LexicalTag NON. ThesaurusID NLM (2013). ... Borderline Cystadenofibroma Term UI T813879. Date12/07/2011. LexicalTag NON. ThesaurusID NLM (2013). ... Benign Cystadenofibroma Term UI T813878. Date12/07/2011. LexicalTag NON. ThesaurusID NLM (2013). ...
Mucinous cystadenofibroma Current Synonym true false Associated Value Sets Value Set Name Version(s) ...
Benign and Borderline Cystadenofibroma of the Ovary Mehmet Coşkun Salman, Nasuh Utku Doğan, Gürkan Bozdağ, Çiğdem Himmetoğlu, ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
Casasola SV, Mindan JP: Cystadenofibroma of the fallopian tube. Appl Pathol. 1989, 7: 256-259. ...
Papillary serous cystadenofibroma is a rare presentation in paraovarian cyst. We report a case of 38 year old female with ... Abstract: Papillary serous cystadenofibroma is a rare presentation in paraovarian cyst. We report a case of 38 year old female ... Keywords: Paraovarian cyst, Papillary serous cystadenofibroma, adnexal mass, reproductive age, asymptomatic. Edition: Volume 4 ... Histopathological examination showed papillary serous cystadenofibroma of paraovarian cyst. ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
... baclofen submission pneumocolon wrinkled tropidechis negishi hook3 hook2 hook1 musci asteroid quattro musca cystadenofibroma ...
MRI Appearance of a Giant Ovarian Sero-mucinous Cystadenofibroma Mimicking Ascites. A Case Report and Brief Literature Review ...
The carcinoma arises in the background of a borderline endometrioid cystadenofibroma. The capsule is free of inv... ... The carcinoma arises in the background of a borderline endometrioid cystadenofibroma. The capsule is free of involvement by ...
MR imaging findings of ovarian cystadenofibroma and cystadenocarcinofibroma: clues for the differential diagnosis ...
serous cystadenoma / serous cystadenofibroma *borderline cystadenoma. *serous cystadenocarcinoma. * mucinous tumors *ovarian ...
serous cystadenoma / serous cystadenofibroma *borderline cystadenoma. *serous cystadenocarcinoma. * mucinous tumors *ovarian ...
serous cystadenoma / serous cystadenofibroma *borderline cystadenoma. *serous cystadenocarcinoma. * mucinous tumors *ovarian ...
Free multilingual online dictionary and synonyms ...
A related tumour, termed an adenofibroma, is a benign, sometimes solid and sometimes cystic (cystadenofibroma) tumour, composed ...
HN - 2013 BX - Cycloaddition MH - Cystadenofibroma UI - D062625 MN - C4.557.450.565.590.595.50.500 MN - C4.557.470.590.482 MN ...
... cystadenofibroma (TUM) X ADENOFIBROMA cystadenoma (unspecified) (TUM) X CYSTADENOBA cystadenoma lymphomatosum, (TUK) papillary ...
  • 1,2,3] Struma ovarii have also been reported with coexisting non-germinal epithelial tumors such as mucinous cystadenoma, Brenner's tumor, and serous cystadenofibroma. (jpgo.org)
  • MRI Appearance of a Giant Ovarian Sero-mucinous Cystadenofibroma Mimicking Ascites. (interdisciplinary.ro)
  • 9. Radioiodine accumulation in a large adnexal cystadenofibroma. (nih.gov)
  • The carcinoma arises in the background of a borderline endometrioid cystadenofibroma. (radiopaedia.org)